Pfizer Inc.
Anti-IL-33 antibodies, compositions, methods and uses thereof
Last updated:
Abstract:
The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to IL-33, as well as uses, and associated methods thereof.
Status:
Grant
Type:
Utility
Filling date:
24 Apr 2017
Issue date:
28 Jan 2020